Under both of those Drake’s and Lynch’s products, the expense of deleterious mutations is what drives mutation rates down (Drake 1991; Lynch 2010; Sung et al. 2012). as a result, under both of those products, a rise in the typical cost of mutations would produce a reduce in mutation costs. to look at this, Drake examined mutation prices of ther